LIFR_HUMAN - dbPTM
LIFR_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID LIFR_HUMAN
UniProt AC P42702
Protein Name Leukemia inhibitory factor receptor
Gene Name LIFR
Organism Homo sapiens (Human).
Sequence Length 1097
Subcellular Localization Isoform 1: Cell membrane
Single-pass type I membrane protein.
Isoform 2: Secreted.
Protein Description Signal-transducing molecule. May have a common pathway with IL6ST. The soluble form inhibits the biological activity of LIF by blocking its binding to receptors on target cells..
Protein Sequence MMDIYVCLKRPSWMVDNKRMRTASNFQWLLSTFILLYLMNQVNSQKKGAPHDLKCVTNNLQVWNCSWKAPSGTGRGTDYEVCIENRSRSCYQLEKTSIKIPALSHGDYEITINSLHDFGSSTSKFTLNEQNVSLIPDTPEILNLSADFSTSTLYLKWNDRGSVFPHRSNVIWEIKVLRKESMELVKLVTHNTTLNGKDTLHHWSWASDMPLECAIHFVEIRCYIDNLHFSGLEEWSDWSPVKNISWIPDSQTKVFPQDKVILVGSDITFCCVSQEKVLSALIGHTNCPLIHLDGENVAIKIRNISVSASSGTNVVFTTEDNIFGTVIFAGYPPDTPQQLNCETHDLKEIICSWNPGRVTALVGPRATSYTLVESFSGKYVRLKRAEAPTNESYQLLFQMLPNQEIYNFTLNAHNPLGRSQSTILVNITEKVYPHTPTSFKVKDINSTAVKLSWHLPGNFAKINFLCEIEIKKSNSVQEQRNVTIKGVENSSYLVALDKLNPYTLYTFRIRCSTETFWKWSKWSNKKQHLTTEASPSKGPDTWREWSSDGKNLIIYWKPLPINEANGKILSYNVSCSSDEETQSLSEIPDPQHKAEIRLDKNDYIISVVAKNSVGSSPPSKIASMEIPNDDLKIEQVVGMGKGILLTWHYDPNMTCDYVIKWCNSSRSEPCLMDWRKVPSNSTETVIESDEFRPGIRYNFFLYGCRNQGYQLLRSMIGYIEELAPIVAPNFTVEDTSADSILVKWEDIPVEELRGFLRGYLFYFGKGERDTSKMRVLESGRSDIKVKNITDISQKTLRIADLQGKTSYHLVLRAYTDGGVGPEKSMYVVTKENSVGLIIAILIPVAVAVIVGVVTSILCYRKREWIKETFYPDIPNPENCKALQFQKSVCEGSSALKTLEMNPCTPNNVEVLETRSAFPKIEDTEIISPVAERPEDRSDAEPENHVVVSYCPPIIEEEIPNPAADEAGGTAQVIYIDVQSMYQPQAKPEEEQENDPVGGAGYKPQMHLPINSTVEDIAAEEDLDKTAGYRPQANVNTWNLVSPDSPRSIDSNSEIVSFGSPCSINSRQFLIPPKDEDSPKSNGGGWSFTNFFQNKPND
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
22PhosphorylationVDNKRMRTASNFQWL
ECCCCCCCHHHHHHH
25.7022210691
64N-linked_GlycosylationTNNLQVWNCSWKAPS
CCCEEEEEEEEECCC
15.87UniProtKB CARBOHYD
85N-linked_GlycosylationDYEVCIENRSRSCYQ
CEEEEEECCCCCEEE
27.58UniProtKB CARBOHYD
131N-linked_GlycosylationKFTLNEQNVSLIPDT
CEEECCCCEEECCCC
21.1118775332
143N-linked_GlycosylationPDTPEILNLSADFST
CCCHHHHCEECCCCC
37.30UniProtKB CARBOHYD
179UbiquitinationWEIKVLRKESMELVK
EEEEEEEHHHHHHEE
50.40-
186UbiquitinationKESMELVKLVTHNTT
HHHHHHEEEEECCCC
50.27-
191N-linked_GlycosylationLVKLVTHNTTLNGKD
HEEEEECCCCCCCCC
25.95UniProtKB CARBOHYD
243N-linked_GlycosylationSDWSPVKNISWIPDS
CCCCCCCCEEECCCC
33.49UniProtKB CARBOHYD
253UbiquitinationWIPDSQTKVFPQDKV
ECCCCCCCEECCCCE
33.95-
303N-linked_GlycosylationNVAIKIRNISVSASS
CEEEEEEEEEEECCC
34.0718775332
367PhosphorylationALVGPRATSYTLVES
EEECCCCCEEEEEEH
24.4425072903
368PhosphorylationLVGPRATSYTLVESF
EECCCCCEEEEEEHH
18.3525072903
369PhosphorylationVGPRATSYTLVESFS
ECCCCCEEEEEEHHC
10.3529759185
370PhosphorylationGPRATSYTLVESFSG
CCCCCEEEEEEHHCC
24.8925072903
374PhosphorylationTSYTLVESFSGKYVR
CEEEEEEHHCCCEEE
19.7525072903
376PhosphorylationYTLVESFSGKYVRLK
EEEEEHHCCCEEEEE
43.5925072903
379PhosphorylationVESFSGKYVRLKRAE
EEHHCCCEEEEEECC
8.3729759185
390N-linked_GlycosylationKRAEAPTNESYQLLF
EECCCCCCHHHHHHH
34.85UniProtKB CARBOHYD
407N-linked_GlycosylationLPNQEIYNFTLNAHN
CCCCEEEEEEECCCC
29.1418775332
426N-linked_GlycosylationSQSTILVNITEKVYP
CCCEEEEECCCCCCC
31.8318775332
445N-linked_GlycosylationSFKVKDINSTAVKLS
EEEEECCCCCEEEEE
43.36UniProtKB CARBOHYD
481N-linked_GlycosylationNSVQEQRNVTIKGVE
CCCCEEECEEEECCC
34.67UniProtKB CARBOHYD
489N-linked_GlycosylationVTIKGVENSSYLVAL
EEEECCCCCEEEEEE
33.57UniProtKB CARBOHYD
490PhosphorylationTIKGVENSSYLVALD
EEECCCCCEEEEEEE
13.57-
491PhosphorylationIKGVENSSYLVALDK
EECCCCCEEEEEEEC
33.78-
492PhosphorylationKGVENSSYLVALDKL
ECCCCCEEEEEEECC
12.67-
526UbiquitinationWSKWSNKKQHLTTEA
HCCCCCCCCCEECCC
47.39-
530PhosphorylationSNKKQHLTTEASPSK
CCCCCCEECCCCCCC
22.0620068231
531PhosphorylationNKKQHLTTEASPSKG
CCCCCEECCCCCCCC
35.5920068231
534PhosphorylationQHLTTEASPSKGPDT
CCEECCCCCCCCCCC
24.3920068231
536PhosphorylationLTTEASPSKGPDTWR
EECCCCCCCCCCCCE
47.9920068231
541PhosphorylationSPSKGPDTWREWSSD
CCCCCCCCCEEECCC
29.5620068231
572N-linked_GlycosylationNGKILSYNVSCSSDE
CCEEEEEEEECCCCH
18.82UniProtKB CARBOHYD
610AcetylationYIISVVAKNSVGSSP
EEEEEEEECCCCCCC
37.847933623
652N-linked_GlycosylationLTWHYDPNMTCDYVI
EEEECCCCCCCCEEE
35.18UniProtKB CARBOHYD
663N-linked_GlycosylationDYVIKWCNSSRSEPC
CEEEECCCCCCCCCC
41.74UniProtKB CARBOHYD
665PhosphorylationVIKWCNSSRSEPCLM
EEECCCCCCCCCCEE
26.3222210691
667PhosphorylationKWCNSSRSEPCLMDW
ECCCCCCCCCCEECC
48.0822210691
680N-linked_GlycosylationDWRKVPSNSTETVIE
CCEECCCCCCCEEEE
47.05UniProtKB CARBOHYD
729N-linked_GlycosylationLAPIVAPNFTVEDTS
HCCEECCCCEECCCC
35.17UniProtKB CARBOHYD
735PhosphorylationPNFTVEDTSADSILV
CCCEECCCCCCEEEE
16.5920068231
736PhosphorylationNFTVEDTSADSILVK
CCEECCCCCCEEEEE
42.2620068231
739PhosphorylationVEDTSADSILVKWED
ECCCCCCEEEEEEEC
19.9620068231
759PhosphorylationLRGFLRGYLFYFGKG
HHHHHHHHHHCCCCC
6.29-
762PhosphorylationFLRGYLFYFGKGERD
HHHHHHHCCCCCCCC
14.61-
787N-linked_GlycosylationRSDIKVKNITDISQK
CCCCEEECCCCCCCC
45.43UniProtKB CARBOHYD
804UbiquitinationRIADLQGKTSYHLVL
EEECCCCCCEEEEEE
22.722063986
807PhosphorylationDLQGKTSYHLVLRAY
CCCCCCEEEEEEEEE
12.3822461510
833PhosphorylationYVVTKENSVGLIIAI
EEEECCCCHHHHHHH
20.75-
866UbiquitinationYRKREWIKETFYPDI
HHHHHHHHHHCCCCC
52.34-
868PhosphorylationKREWIKETFYPDIPN
HHHHHHHHCCCCCCC
24.3830622161
870PhosphorylationEWIKETFYPDIPNPE
HHHHHHCCCCCCCHH
13.8630622161
880UbiquitinationIPNPENCKALQFQKS
CCCHHHCCHHHHHHH
64.81-
880AcetylationIPNPENCKALQFQKS
CCCHHHCCHHHHHHH
64.81125711803
886AcetylationCKALQFQKSVCEGSS
CCHHHHHHHHHCCCC
46.26125711801
886UbiquitinationCKALQFQKSVCEGSS
CCHHHHHHHHHCCCC
46.26-
887PhosphorylationKALQFQKSVCEGSSA
CHHHHHHHHHCCCCC
22.6330576142
896UbiquitinationCEGSSALKTLEMNPC
HCCCCCCCEEECCCC
51.27-
896AcetylationCEGSSALKTLEMNPC
HCCCCCCCEEECCCC
51.27125711799
904PhosphorylationTLEMNPCTPNNVEVL
EEECCCCCCCCEEEE
30.2421815630
923PhosphorylationAFPKIEDTEIISPVA
CCCCCCCCEEECCCC
19.1230266825
927PhosphorylationIEDTEIISPVAERPE
CCCCEEECCCCCCCC
20.9830266825
974PhosphorylationGGTAQVIYIDVQSMY
CCEEEEEEEEEHHCC
7.6922817900
1041PhosphorylationVNTWNLVSPDSPRSI
CCCEEECCCCCCCCC
26.5925159151
1044PhosphorylationWNLVSPDSPRSIDSN
EEECCCCCCCCCCCC
26.1218624908
1047PhosphorylationVSPDSPRSIDSNSEI
CCCCCCCCCCCCCCE
33.8525159151
1050PhosphorylationDSPRSIDSNSEIVSF
CCCCCCCCCCCEEEE
40.3525159151
1052PhosphorylationPRSIDSNSEIVSFGS
CCCCCCCCCEEEECC
32.4330576142
1056PhosphorylationDSNSEIVSFGSPCSI
CCCCCEEEECCCCEE
29.5622210691
1059PhosphorylationSEIVSFGSPCSINSR
CCEEEECCCCEECCC
22.2630576142
1062PhosphorylationVSFGSPCSINSRQFL
EEECCCCEECCCCCC
28.3427307780
1065PhosphorylationGSPCSINSRQFLIPP
CCCCEECCCCCCCCC
26.2827307780
1077PhosphorylationIPPKDEDSPKSNGGG
CCCCCCCCCCCCCCC
31.9830266825
1080PhosphorylationKDEDSPKSNGGGWSF
CCCCCCCCCCCCCCH
44.0522210691
1086PhosphorylationKSNGGGWSFTNFFQN
CCCCCCCCHHHHCCC
26.0122210691
1088PhosphorylationNGGGWSFTNFFQNKP
CCCCCCHHHHCCCCC
26.1222210691

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
1044SPhosphorylationKinaseMK01P28482
PhosphoELM
1044SPhosphorylationKinaseMAPK1P63086
GPS
1044SPhosphorylationKinaseMK03P27361
PhosphoELM
1044SPhosphorylationKinaseMAPK3P21708
GPS
1044SPhosphorylationKinaseMAPK-FAMILY-GPS
1044SPhosphorylationKinaseMAPK_GROUP-PhosphoELM

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of LIFR_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of LIFR_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CNTFR_HUMANCNTFRphysical
12707266
LIF_HUMANLIFphysical
12601009
ONCM_HUMANOSMphysical
1536831
IL6RB_HUMANIL6STphysical
12047380
PTN6_HUMANPTPN6physical
10800945

Drug and Disease Associations
Kegg Disease
H00462 Stuve-Wiedemann syndrome
OMIM Disease
601559Stueve-Wiedemann syndrome (STWS)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of LIFR_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Structural organization of a full-length gp130/LIF-R cytokinereceptor transmembrane complex.";
Skiniotis G., Lupardus P.J., Martick M., Walz T., Garcia K.C.;
Mol. Cell 31:737-748(2008).
Cited for: X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 52-534, IDENTIFICATION IN ACOMPLEX WITH IL6ST; CNTF AND CNTFR, GLYCOSYLATION AT ASN-131; ASN-303;ASN-407 AND ASN-426, DISULFIDE BONDS, ELECTRON MICROSCOPY, ANDSUBUNIT.
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-927, AND MASSSPECTROMETRY.

TOP